Cargando…
End-Stage Heart Failure With COVID-19: Strong Evidence of Myocardial Injury by 2019-nCoV
Autores principales: | Dong, Nianguo, Cai, Jie, Zhou, Ying, Liu, Junwei, Li, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American College of Cardiology Foundation. Published by Elsevier.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141452/ https://www.ncbi.nlm.nih.gov/pubmed/32265149 http://dx.doi.org/10.1016/j.jchf.2020.04.001 |
Ejemplares similares
-
Changes in transcriptomic landscape in human end-stage heart failure with distinct etiology
por: Zhu, Miaomiao, et al.
Publicado: (2022) -
Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity
por: Chen, Weilie, et al.
Publicado: (2020) -
Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia
por: Song, Fengxiang, et al.
Publicado: (2020) -
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
por: Russell, Clark D, et al.
Publicado: (2020) -
An update on the 2019-nCoV outbreak
por: Ammad Ud Din, Mohammad, et al.
Publicado: (2020)